DK164938B - 2BETA-CHLORMETHYL-2ALFA-METHYL-6ALFA-BROMPENAM-3ALFA-CARBOXYLIC ACID ESTES AND PROCEDURES FOR PREPARING THEREOF - Google Patents
2BETA-CHLORMETHYL-2ALFA-METHYL-6ALFA-BROMPENAM-3ALFA-CARBOXYLIC ACID ESTES AND PROCEDURES FOR PREPARING THEREOF Download PDFInfo
- Publication number
- DK164938B DK164938B DK285890A DK285890A DK164938B DK 164938 B DK164938 B DK 164938B DK 285890 A DK285890 A DK 285890A DK 285890 A DK285890 A DK 285890A DK 164938 B DK164938 B DK 164938B
- Authority
- DK
- Denmark
- Prior art keywords
- nitrobenzyl
- acid
- methyl
- brompenam
- sulfoxide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Cephalosporin Compounds (AREA)
Description
iin
DK 164938 BDK 164938 B
Den foreliggende opfindelse vedrører hidtil ukendte 2/l-chlormethyl-2a-methyl-6a-brompenam-3a-carboxylsyreestere med den nedenfor viste formel (III) samt en fremgangsmåde til fremstilling deraf. Esterene ifølge opfindelsen er værdifulde udgangsforbindelser ved fremstilling af 5 2ji-chlormethyl-2ar-methylpenam-3a-carboxyl syresul fon omhandlet i dansk patentansøgning nr. 218/81.The present invention relates to novel 2/1-chloromethyl-2a-methyl-6a-brompenam-3a-carboxylic acid esters of formula (III) below, and to a process for their preparation. The esters of the invention are valuable starting compounds in the preparation of 5β-chloromethyl-2ar-methylpenam-3α-carboxylic acid sulfone disclosed in Danish Patent Application No. 218/81.
Ved fremgangsmåden ifølge dansk patentansøgning nr. 218/81 eks. 1 kan der fremstilles 2/J-chlormethyl-2a-methylpenam-3a-carboxyl syresul fon med formlen 10 o o CH_C1 r-/ ^ 2 (I) //CH3 ΪΟΟΗ 15 et farmaceutisk acceptabelt salt af syren eller en let hydrolyserbar ester af syren ved, at man i rækkefølge a) i et inert opløsningsmiddel, fortrinsvis methylenchlorid oxi-20 derer en 2/3-chlormethyl-2a-methyl-6a~brompenam-3Q!-carboxyl syreester med formlenBy the process of Danish Patent Application No. 218/81 Example 1, 2 / J-chloromethyl-2a-methylpenam-3a-carboxylic acid sulfone of the formula 10o CH_C1 r- / 2 (I) // CH3 ΪΟΟΗ pharmaceutically acceptable salt of the acid or a readily hydrolyzable ester of the acid by oxidizing, in order a) in an inert solvent, preferably methylene chloride, a 2/3-chloromethyl-2a-methyl-6a-brompenam-3Q-carboxyl acid residues of the formula
BrV_^s\/H2C1 I Cii3 (III)BrV_ ^ s \ / H2C1 I Cii3 (III)
J_N-LJ_N-L
25 <y *j|-0R25 <y * j | -0R
hvori R betegner benzyl eller p-nitrobenzyl, ved omkring stuetemperatur 30 ved anvendelse af en persyre, fortrinsvis m-chlor-peroxybenzoesyre b) katalytisk hydrogenerer, f.eks. med en ædelmetal katalysator, såsom palladium, en ester med formlen £ ch2c1 ,, BIS_ 35 Γ " ch3 (ii) λ-N — \ χwherein R represents benzyl or p-nitrobenzyl, at about room temperature 30 using a peracid, preferably m-chloro-peroxybenzoic acid; b) catalytic hydrogenates, e.g. with a precious metal catalyst such as palladium, an ester of the formula £ ch2c1, BIS_ 35 Γ "ch3 (ii) λ-N - \ χ
CO-RCO-R
O 2 2O 2 2
DK 164938 BDK 164938 B
hvori R* betegner benzyl el-ler p-nitrobenzyl, og dernæst c) underkaster det hydrogenerede produkt oxidation til fremstilling af den ønskede syre eller et salt deraf, og dernæst om-ønsket d) esterificerer syren eller et salt deraf til dannelse af en let 5 hydrolyserbar ester af syren.wherein R * represents benzyl or p-nitrobenzyl, and then c) the hydrogenated product undergoes oxidation to produce the desired acid or salt thereof, and then, if desired, d) esterifies the acid or a salt thereof to form a light. 5 hydrolyzable ester of the acid.
Særligt værdifulde beskyttende grupper for R* er benzylgruppen og p-nitrobenzyl. Benzyl eller p-nitrobenzylgruppen kan bekvemt fjernes ved katalytisk hydrogenering. I dette tilfælde omrøres eller rystes en opløsning i et inert opløsningsmiddel af forbindelsen med formlen (II), 10 hvori R* betegner benzyl eller p-nitrobenzyl, under en atmosfære af hydrogen eller hydrogen blandet med et inert fortyndingsmiddel, såsom nitrogen eller argon, i nærværelse af en katalytisk mængde af en hydrogeneringskatalysator. Egnede opløsningsmidler til denne hydrogenering er lavere al kano!er, såsom methanol, ethere, såsom tetrahydrofuran og 15 dioxan, lavmolekylære estere, såsom ethylacetat og butylacetat, vand, og blandinger af disse opløsningsmidler. Det er imidlertid normalt at vælge betingelser, under hvilke udgangsmaterialet er opløseligt. Hydrogeneringen udføres sædvanligvis ved en temperatur i intervallet fra ca. 0 til ca. 60°C og ved et tryk i intervallet fra ca. 1 til ca. 100 kg/cm2.Particularly valuable protecting groups for R * are the benzyl group and p-nitrobenzyl. The benzyl or p-nitrobenzyl group can be conveniently removed by catalytic hydrogenation. In this case, a solution in an inert solvent is stirred or shaken by the compound of formula (II) wherein R * represents benzyl or p-nitrobenzyl, under an atmosphere of hydrogen or hydrogen mixed with an inert diluent such as nitrogen or argon. the presence of a catalytic amount of a hydrogenation catalyst. Suitable solvents for this hydrogenation are lower all channels such as methanol, ethers such as tetrahydrofuran and dioxane, low molecular weight esters such as ethyl acetate and butyl acetate, water, and mixtures of these solvents. However, it is normal to choose conditions under which the starting material is soluble. The hydrogenation is usually carried out at a temperature in the range of about 0 to approx. 60 ° C and at a pressure in the range of approx. 1 to approx. 100 kg / cm 2.
20 De til denne hydrogeneringsreaktion anvendte katalysatorer er af den type, som kendes inden for denne transformationsteknik, og typiske eksempler er ædle metaller, såsom nikkel, palladium, platin og rhodium. Katalysatoren er sædvanligvis til stede i en mængde fra ca. 0,01 til ca.The catalysts used for this hydrogenation reaction are of the type known in the art of transformation, and typical examples are precious metals such as nickel, palladium, platinum and rhodium. The catalyst is usually present in an amount of approx. 0.01 to approx.
2,5 vægtprocent, og fortrinsvis fra ca. 0,1 til ca. 1,0 vægtprocent 25 baseret på forbindelsen med formlen A. Det er ofte hensigtsmæssigt at suspendere katalysatoren på en inert bærer; en særligt hensigtsmæssig katalysator er palladium suspenderet på en inert bærer, såsom carbon.2.5% by weight, and preferably from ca. 0.1 to approx. 1.0% by weight based on the compound of formula A. It is often convenient to suspend the catalyst on an inert carrier; a particularly suitable catalyst is palladium suspended on an inert carrier such as carbon.
Der er endvidere sædvanligt at pufferindstille reaktionsblandingen for at arbejde ved en pH-værdi i intervallet fra ca. 4 til 9, og fortrins-30 vis fra 6 til 8. Borat- og phosphatpuffere anvendes normalt. Reaktionen tager typisk ca. 1 time.Furthermore, it is customary to buffer the reaction mixture to operate at a pH in the range of from ca. 4 to 9, and preferably from 6 to 8. Borate and phosphate buffers are normally used. The reaction typically takes approx. 1 hour.
Den hidtil ukendte udgangsforbindelse ifølge opfindelsen har formi en „ „ CH-ClThe novel starting compound of the invention is in the form of an "CH" Cl
Br / 2 35 **-p f/CH3 (111) __N- a * r 3Br / 2 35 ** - p f / CH3 (111) __N- a * r 3
DK 164938 BDK 164938 B
hvori R betegner benzyl eller p-nitrobenzyl, og fremstilles ved en fremgangsmåde, der er ejendommelig ved, at man opvarmer, fortrinsvis under tilbagesvaling, en forbindelse med formlen 5 Br ·$ 7 '4a- ’ (IV)wherein R is benzyl or p-nitrobenzyl and is prepared by a process which is characterized by heating, preferably under reflux, a compound of the formula 5 Br · $ 7 '4a' (IV)
Vorour
U IIU II
10 0 hvori R betegner benzyl eller p-nitrobenzyl, i et inert vandfrit organisk opløsningsmiddel, fortrinsvis dioxan, i nærværelse af store og fortrinsvis ækvimolære mængder af en svag tertiær amin, fortrinsvis quinolin, og et syrechlorid, fortrinsvis benzoylchlorid, indtil reak-15 tionen i det væsentlige er løbet til ende.Wherein R represents benzyl or p-nitrobenzyl, in an inert anhydrous organic solvent, preferably dioxane, in the presence of large and preferably equimolar amounts of a weak tertiary amine, preferably quinoline, and an acid chloride, preferably benzoyl chloride, until essentially the race has come to an end.
"Skellysol ve B" er en petroleumsetherfraktion med kogepunkt 60-68°C bestående i det væsentlige af n-hexan ("Skellysolve" er et handelsnavn fra Skelly Oil Co.)."Skellysolve B" is a petroleum ether fraction having a boiling point of 60-68 ° C consisting essentially of n-hexane ("Skellysolve" is a trade name of Skelly Oil Co.).
Fremgangsmåderne ifølge opfindelsen belyses nærmere i de følgende 20 eksempler.The methods of the invention are elucidated in the following Examples.
44
DK 164938 BDK 164938 B
Eksempel 1Example 1
Fremst i 11 i ng af p-ni trobenzyl -21-chl ormet hyl -2o;-methyl -6tt-brompenam-3a-carboxylat) 5 0 o ar - t ' t :_ o N ^CO H J- N : ^ /—\ io 2 co2-ch2-^o)-no2 — 2 Ψ 15Primarily in 11 µg of p-ni trobenzyl-21-chloro oryl-20; -methyl-6tt-brompenam-3α-carboxylate) 0 0 ar - t: _ o N ^ CO H J- N: ^ / - \ io 2 co2-ch2- ^ o) -no2 - 2 Ψ 15
Br%_^s^Æcl Z* Vch2<0>™2 20 3_ 25 6a;-brompeni ci 11 ansyre-S-sul foxid (1) 1. 30 g (37,5 mmol) 6a-brompenicillansyre, N,N'-di benzyl ethylen-diaminsalt [6. Cignarella et al., J. Org. Chem. 27, 2668 (1962) og E. Evrard, Nature 201, 1124 (1964)] opløses i 330 ml methylenchlorid.Br% _ ^ s ^ Acl Z * Vch2 <0> ™ 2 20 3_ 25 6a; -brompenic in 11 anic acid-S-sulphoxide (1) 1. 30 g (37.5 mmol) of 6a-brompenicillanic acid, N, N -di benzyl ethylene diamine salt [6. Cignarella et al., J. Org. Chem. 27, 2668 (1962) and E. Evrard, Nature 201, 1124 (1964)] are dissolved in 330 ml of methylene chloride.
Der omrøres og afkøles til 0°C.Stir and cool to 0 ° C.
30 2. 13 ml (156 mmol) koncentreret saltsyre sættes langsomt til methylenchloridopløsningen. Udfældning af dibenzyl ethylendiamin, HC1-saltet (DBED,HC1) finder sted i løbet af et minut. Opslæmningen omrøres ved 0-5°C i 10 minutter.2. 13 ml (156 mmol) of concentrated hydrochloric acid are slowly added to the methylene chloride solution. Precipitation of the dibenzyl ethylenediamine, HCl salt (DBED, HCl) occurs within one minute. The slurry is stirred at 0-5 ° C for 10 minutes.
3. Bundfaldet af DBED,HC1 filtreres gennem et forbelagt diatomé-35 jord-filter ("Dicalite"). Kagen vaskes med 150 ml methylenchlorid. Filtreringen bør afsluttes så hurtigt som muligt. Man bør undgå at opbevare den sure methylenchloridopløsning i længere tidsrum. Der kan være nogle filtreringsproblemer på grund af bundfaldets fine natur. Tilsætning af 53. The precipitate of DBED, HC1 is filtered through a pre-coated diatomaceous earth filter ("Dicalite"). The cake is washed with 150 ml of methylene chloride. Filtering should be completed as soon as possible. The acidic methylene chloride solution should be stored for a prolonged period of time. There may be some filtering problems due to the fine nature of the precipitate. Addition of 5
DK 164938 BDK 164938 B
filterhjælpemiddel til opslæmningen kan være til hjælp.slurry filter aid may be helpful.
4. Blandingen af methylenchloridfil trat og vaskevæske vaskes med 60 ml koldt vand. Der omrøres 5 minutter, og den vandige fase kasseres. Vaskevæskens pH-værdi er 2,0-2,3.4. Wash the mixture of methylene chloride filtrate and washing liquid with 60 ml of cold water. Stir for 5 minutes and discard the aqueous phase. The pH of the wash liquid is 2.0-2.3.
5 5. Methyl enchl ori dopi øsn i ngen, som indeholder 6a-brompenici Han- syre, koncentreres under reduceret tryk til et volumen på 65-80 ml. Opløsningen afkøles og omrøres til 5°C.5 5. Methyl enchl ori dopi ssion containing 6a-brompenic maleic acid is concentrated under reduced pressure to a volume of 65-80 ml. The solution is cooled and stirred to 5 ° C.
6. Under kraftig omrøring tilsættes forsigtigt 13 ml (86,9 mmol) 40% pereddikesyre over et tidsrum af 30 minutter. Reaktionen er exoterm.6. With vigorous stirring, carefully add 13 ml (86.9 mmol) of 40% peracetic acid over a period of 30 minutes. The reaction is exothermic.
10 Temperaturen holdes mellem 15 og 18°C med isbadafkøling. Sulfoxidet begynder at udkrystallisere, efter at 10 ml persyre er tilsat. Opslæmningen afkøles og omrøres ved 0-5°C i 2 timer.10 The temperature is kept between 15 and 18 ° C with ice bath cooling. The sulfur oxide begins to crystallize after adding 10 ml of peracid. The slurry is cooled and stirred at 0-5 ° C for 2 hours.
7. Den snehvide kage filtreres og vaskes med 10 ml 5°C vand, dernæst med 10 ml 0-5°C methylenchlorid og endelig vaskes med 15 ml heptan.7. The snow white cake is filtered and washed with 10 ml of 5 ° C water, then with 10 ml of 0-5 ° C methylene chloride and finally washed with 15 ml of heptane.
15 8. Kagen tørres i luftovn ved 45°C til konstant vægt, hvorved ca.8. The cake is dried in an oven at 45 ° C to constant weight, whereby approx.
6-10 timer bør være tilstrækkelig. Overdreven opvarmning kan udvikle spor af en lyserødlig farve. Vægten af 1 er ca. 16,26 g, udbytte 73,24%.6-10 hours should be sufficient. Excessive warming can develop traces of a pinkish color. The weight of 1 is approx. 16.26 g, yield 73.24%.
9. Reaktionsblandingen og slutproduktet kan analyseres ved tyndt-lagskromatografi under anvendelse af opløsningsmiddel systemer bestående 20 af 15 dele toluen/4 dele acetone/1 del eddikesyre (HAC) eller 8 dele acetone/8 dele methanol/3 dele toluen/1 del HAC. Slutproduktet analyseres ved NMR og IR.9. The reaction mixture and final product can be analyzed by thin layer chromatography using solvent systems consisting of 20 parts of 15 parts of toluene / 4 parts of acetone / 1 part of acetic acid (HAC) or 8 parts of acetone / 8 parts of methanol / 3 parts of toluene / 1 part of HAC. The final product is analyzed by NMR and IR.
p-nitrobenzyl-6a-brompenicinanat-S-su1foxid (2) 25 Til en opløsning af 12 g (0,04 mol) 6o;-brompenicillansyre-S-sulf-oxid i 100 ml acetone sattes 7,5 g (0,041 mol) kalium-2-ethylhexanoat.p-Nitrobenzyl-6a-brompenicinanate S-sulfoxide (2) To a solution of 12 g (0.04 mole) 620; -brompenicillanic acid S-sulfoxide in 100 ml of acetone was added 7.5 g (0.041 mole) potassium 2-ethylhexanoate.
Saltet opsamledes ved filtrering, vaskedes med kold acetone og lufttørredes til et udbytte på ialt 10 g. Det krystallinske kaliumsalt opløstes i 75 ml dimethylacetamid, og 7,8 g (0,04 mol) p-nitrobenzyl-30 bromid tilsattes. Opløsningen omrørtes ved 23°C i 24 timer. Blandingen fortyndedes med 500 ml vand og ekstraheredes med ethyl acetat. Ethyl-acetatlaget vaskedes fire gange med vand og tørredes over vandfri magnesiumsulfat. Opløsningsmidlet afdampedes ved 35°C (15 mm) til en olie, der krystalliserede. De lyst tanfarvede krystaller af 2 opslæmme-35 des med ether og opsamledes ved filtrering til et udbytte på 9 g (70%), smp. 124-125°C dek.The salt was collected by filtration, washed with cold acetone and air-dried to yield a total of 10 g. The crystalline potassium salt was dissolved in 75 ml of dimethylacetamide and 7.8 g (0.04 mole) of p-nitrobenzyl bromide was added. The solution was stirred at 23 ° C for 24 hours. The mixture was diluted with 500 ml of water and extracted with ethyl acetate. The ethyl acetate layer was washed four times with water and dried over anhydrous magnesium sulfate. The solvent was evaporated at 35 ° C (15 mm) to an oil which crystallized. The light tan crystals of 2 were slurried with ether and collected by filtration to yield 9 g (70%), m.p. 124-125 ° C dec.
66
DK 164938 BDK 164938 B
Analyse for C15H15BrN2°6S:Analysis for C 15 H 15 BrN 2 ° 6S:
Beregnet: C: 41,98, H: 3,05, N: 6,52 Fundet: C: 42,00, H: 3,48, N: 6,98.Calculated: C: 41.98, H: 3.05, N: 6.52 Found: C: 42.00, H: 3.48, N: 6.98.
IR(KBr): 1800(s), 1740(s), 1610(w), 1520(s), 1450(m), 1350(s), 5 1060(m), 740(m) cm*1.IR (KBr): 1800 (s), 1740 (s), 1610 (w), 1520 (s), 1450 (m), 1350 (s), 1060 (m), 740 (m) cm
H-NMR (60 mHz, DHS0)5: 1,22 (s, 3H), 1,6 (s, 3H), 4,67 (s, IH), 5,2 (d, J—1-5 Hz, IH), 5,45 (s, 2H), 5,68 (d, J-l-5 Hz, IH), 7,5-8,5 (m, 4H).H-NMR (60 mHz, DHSO) δ: 1.22 (s, 3H), 1.6 (s, 3H), 4.67 (s, 1H), 5.2 (d, J-1-5 Hz) , 1H), 5.45 (s, 2H), 5.68 (d, Jl-5 Hz, 1H), 7.5-8.5 (m, 4H).
10 p-nitrobenzyl-2^-chlormethyl-2ot-methyl -6-broropenam-3tt-carboxyl at (3)10-p-nitrobenzyl-2β-chloromethyl-2-methyl-6-broropenam-3β-carboxyl (3)
En opløsning af 5 g (0,012 mol) p-nitrobenzyl-6a-brompenici11 anat- S-sulfoxid (2) i 120 ml vandfri dioxan opvarmedes ved tilbagesvaling under nitrogen i 4 timer med 1,5 g (0,012 mol) quinolin og 1,6 g (0,012 mol) benzoylchlorid. Opløsningen fortyndedes med 600 ml vand og 15 ekstraheredes med ethyl acetat. Ethyl acetatekstrakten vaskedes med 5% natriumbicarbonatopløsning, 5% phosphorsyreopløsning og endelig med vand. Det organiske lag tørredes over vandfri magnesiumsulfat og inddampedes til en olie ved 35°C (15 mm). Olien krystalliserede og opsam-ledes, vaskedes med ether og endelig med kold toluen til et udbytte af 20 3, 3,5 g (65%), smp. 130-135°C dek.A solution of 5 g (0.012 mole) of p-nitrobenzyl-6a-brompenicillanate S-sulfoxide (2) in 120 ml of anhydrous dioxane was heated at reflux under nitrogen for 4 hours with 1.5 g (0.012 mole) of quinoline and 1 6 g (0.012 mol) of benzoyl chloride. The solution was diluted with 600 ml of water and extracted with ethyl acetate. The ethyl acetate extract was washed with 5% sodium bicarbonate solution, 5% phosphoric acid solution and finally with water. The organic layer was dried over anhydrous magnesium sulfate and evaporated to an oil at 35 ° C (15 mm). The oil crystallized and collected, washed with ether and finally with cold toluene to give a yield of 3.5, 3.5 g (65%), m.p. 130-135 ° C dec.
Analyse for CjgHjgCIBrNgOgS:Analysis for CjgHjgCIBrNgOOS:
Beregnet: C: 40,06, H: 3,14, N: 6,23,Calculated: C: 40.06, H: 3.14, N: 6.23,
Fundet: C: 40,19, H: 3,12, N: 6,75.Found: C: 40.19, H: 3.12, N: 6.75.
IR(KBr): 1792(s), 1740(s), 1610(w), 1520(s), 1353(s), 1280(m), 25 1025(w), 990(w), 750(w) cm"1.IR (KBr): 1792 (s), 1740 (s), 1610 (w), 1520 (s), 1353 (s), 1280 (m), 10,1025 (w), 990 (w), 750 (w) cm "1.
NMR (60mHz, DMS0)i: 1,45 (s, 3H), 3,5-4,3 (m, 2H), 5,05 (s, IH), 5,42 (s, 2H), 5,5 (d, J-1,5 Hz, IH), 5,62 (d, J-1,5 Hz, IH), 7,5-8,5 (m, 4H).NMR (60mHz, DMSO) i: 1.45 (s, 3H), 3.5-4.3 (m, 2H), 5.05 (s, 1H), 5.42 (s, 2H), δ 5 (d, J-1.5 Hz, 1H), 5.62 (d, J-1.5 Hz, 1H), 7.5-8.5 (m, 4H).
30 730 7
DK 164938 BDK 164938 B
Eksempel 2Example 2
Fremstilling af udgangsmaterialet p-nitrobenzyl-6oc-brompeni ci Hi natsul f oxidPreparation of the starting material p-nitrobenzyl-6oc-brompenic acid in sodium sulfide oxide
5 O5 O
Br Τ' *Br Τ '*
Ir-! +· TEA + BrCH2-</ )^N0o >_ (101) O %0 H (2l6) 10 (296) v/Ir! + · TEA + BrCH2 - </) ^ NOO> _ (101) O% 0 H (2l6) 10 (296) v /
Br·*. Jy 15 \ -V ^ ^ /=\ ° C02CV^Jv- N02 20 ' (431.28)Br · *. You 15 \ -V ^^ / = \ ° C02CV ^ Jv- N02 20 '(431.28)
Fremgangsmåde:Course of action:
Til 200 ml N,N-dimethylacetamid sattes 44 g (0,148 mol) 6a-brom-25 penicillansyre-sulfoxid efterfulgt af 20,5 ml (0,148 mol) triethylamin og 38,2 g (0,177 mol) p-nitrobenzylbromid. Der omrørtes ved 22° i 20 timer.To 200 ml of N, N-dimethylacetamide was added 44 g (0.148 mole) of 6a-bromo-penicillanic acid sulfoxide followed by 20.5 ml (0.148 mole) of triethylamine and 38.2 g (0.177 mole) of p-nitrobenzyl bromide. Stir at 22 ° for 20 hours.
Reaktionsblandingen heldtes i 1 liter HgO og ekstraheredes i 3 x 300 ml methylenchlorid. De forenede methylchloridekstrakter vaskedes 30 med 200 ml 5% vandig natriumbicarbonatopløsning og tørredes over natriumsulfat ved 5° i en halv time. Opløsningen filtreredes og inddampedes under vakuum til en remanens. Remanensen fortyndedes med ether, og faststoffet opsamledes ved filtrering til et udbytte på 54 g p-nitro-benzyl-6a-brompenicillinat-sulfoxid efter tørring. Udbytte 85%. NMR var 35 konsistent for strukturen.The reaction mixture was poured into 1 liter of HgO and extracted into 3 x 300 ml of methylene chloride. The combined methyl chloride extracts were washed with 200 ml of 5% aqueous sodium bicarbonate solution and dried over sodium sulfate at 5 ° for half an hour. The solution was filtered and evaporated under vacuum to a residue. The residue was diluted with ether and the solid collected by filtration to yield 54 g of p-nitrobenzyl-6a-brompenicillinate sulfoxide after drying. Yield 85%. NMR was consistent for structure.
Udbyttet i dette trin var det samme som for K-salt-esterificerin-gen. Fordelen var, at det ikke var nødvendigt at fremstille K-saltet.The yield in this step was the same as for the K-salt esterification. The advantage was that it was not necessary to prepare the K salt.
(Et trin som forløber med et udbytte på 85-90%).(A step that proceeds with a yield of 85-90%).
88
DK 164938 BDK 164938 B
Eksempel 3Example 3
Fremstilling af udgangsmaterialet p-nitrobenzyl-6o;-brompenici 11 anat -sulfoxidPreparation of the starting material p-nitrobenzyl-60; brompenic acid 11 anate sulfoxide
Til 4,375 liter Ν,Ν-dimethylacetamid sattes 873,0 g (2,95 mol) 5 6a-brompeniciliansyre-(S)-sulfoxid og derpå, under omrøring og medens den indre temperatur holdtes under 35°C, 293 g (2,95 mol) triethylamin efterfulgt af 764 g (3,54 mol) p-nitrobenzylbromid. Blandingen omrørtes derpå ved stuetemperatur i 5 timer og henstod natten over.To 4,375 liters of Ν, Ν-dimethylacetamide was added 873.0 g (2.95 mole) of 6α-brompenicilic acid (S) sulfoxide and then, with stirring and while keeping the internal temperature below 35 ° C, 293 g (2). 95 moles of triethylamine followed by 764 g (3.54 moles) of p-nitrobenzyl bromide. The mixture was then stirred at room temperature for 5 hours and left overnight.
Reaktionsblandingen hældtes i 20 liter vand og ekstraheredes med 10 3x7 liter methylenchlorid. De forenede organiske ekstrakter vaskedes med 5x7 liter vand og derpå med 7 liter 5% vandig natriumbicarbonat-opløsning og tørredes over magnesiumsulfat.The reaction mixture was poured into 20 liters of water and extracted with 10 3 x 7 liters of methylene chloride. The combined organic extracts were washed with 5x7 liters of water and then with 7 liters of 5% aqueous sodium bicarbonate solution and dried over magnesium sulfate.
Hagnesiumsulfatet frafiltreredes, og opløsningen inddampedes til en krystallinsk remanens; 4 liter diethylether tilsattes, og krystallerne 15 opsamledes, hvilket gav et udbytte efter tørring ved stuetemperatur på 1171 g (92%) p-nitrobenzyl-6a-brompenicillanat-sulfoxid.The magnesium sulfate was filtered off and the solution evaporated to a crystalline residue; 4 liters of diethyl ether were added and the crystals were collected to yield, after drying at room temperature, 1171 g (92%) of p-nitrobenzyl-6a-brompenicillanate sulfoxide.
Br 18,48% (beregnet 18,53%), <*D (0,25% MeOH) + 162°.Br 18.48% (calculated 18.53%), <* D (0.25% MeOH) + 162 °.
Eksempel 4 20 Fremstilling af udgangsmaterialet 6o;-brompenicinansyre-sulfoxid i— — 0 +Example 4 Preparation of the starting material 60; -brompenicinanoic acid sulfoxide in - - +
Br,_Br ΓΧ/ —> DJ* '6 ^o2e: o ^co2h MW 800.64 MW 296.14 30Br, _Br ΓΧ / -> DJ * '6 ^ o2e: o ^ co2h MW 800.64 MW 296.14 30
Til 3 liter methylenchlorid sattes 300 g (0,75 mol) 6a-brompenicil-lansyre-N,N'-dibenzylethylendiaminsalt, og denne suspension afkøledes til 5°. Derpå tilsattes i løbet af 15 minutter under god omrøring 130 ml koncentreret HC1 dråbevis. Opslæmningen omrørtes ved 5° i 2 timer. Den 35 filtreredes så gennem en ("Celite") pude af diatoméjord, og kagen vaskedes med 3 x 250 ml methylenchlorid.To 3 liters of methylene chloride was added 300 g (0.75 mol) of 6α-brompenicilanoic acid N, N'-dibenzylethylenediamine salt and this suspension was cooled to 5 °. Then, under good stirring, 130 ml of concentrated HCl was added dropwise over 15 minutes. The slurry was stirred at 5 ° for 2 hours. It was then filtered through a ("Celite") pad of diatomaceous earth and the cake washed with 3 x 250 ml of methylene chloride.
De forenede methylenchloridopiøsninger vaskedes med 2 x 500 ml HgO og tørredes over natriumsulfat i 15 minutter. Natriumsulfatet fjernedesThe combined methylene chloride solutions were washed with 2 x 500 ml HgO and dried over sodium sulfate for 15 minutes. The sodium sulfate was removed
DK 164938BDK 164938B
9 ved filtrering, og filtratet inddampedes under reduceret tryk til ca.9 by filtration and the filtrate was evaporated under reduced pressure to ca.
750 ml.750 ml.
Denne opløsning afkøledes til 5° og under kraftig -omrøring tilsattes 130 ml 40% pereddikesyre dråbevis, således at temperaturen holdtes 5 ved 5-12°. Tilsætningen var helt exotermisk. Ved slutningen af tilsætningen omrørtes opslæmningen ved 5° i 2 timer, og produktet opsamledes ved filtrering og vaskedes med 100 ml kold H20 (5°) og 100 ml kold methylenchlorid (5°). Der opnåedes 126 g (57%) 6ar-brompen i ci 11 ansyre-sulfoxid, smp. 129°. IR- og NMR-spektrene var konsistente for det 10 ønskede produkt.This solution was cooled to 5 ° and, with vigorous stirring, 130 ml of 40% peracetic acid was added dropwise, keeping the temperature 5 at 5-12 °. The addition was completely exothermic. At the end of the addition, the slurry was stirred at 5 ° for 2 hours, and the product was collected by filtration and washed with 100 ml of cold H2 O (5 °) and 100 ml of cold methylene chloride (5 °). 126 g (57%) of the 6ar bromine were obtained in c1 11 anic acid sulfoxide, m.p. 129 °. The IR and NMR spectra were consistent for the desired product.
Analyse for Cg H10BrN04S:Analysis for Cg H10BrNO4S:
Beregnet: C: 32,44, H: 3,40, N: 4,73.Calculated: C: 32.44, H: 3.40, N: 4.73.
Fundet: C: 32,30, H: 3,35, N: 4,71, H20: 2,18.Found: C: 32.30, H: 3.35, N: 4.71, H 2 O: 2.18.
15 Fremstilling af udgangsmaterialet kalium-6a-brompenicillanat-sulfoxidPreparation of the starting material potassium 6a-brompenicillanate sulfoxide
OISLAND
0 „ ♦0 "♦
t B? .St B? .S
. 'Tfx — TO-. 'Tfx - TO-
O %C02HO% CO 2 H
..MW..MW
25 Til 3 liter acetone sattes 126 g (0,43 mol) 6a-brompenicillansyre-sulfoxid og 162 ml 50 vægtprocent kalium-2-ethylhexansyre i n-butanol.To 3 liters of acetone was added 126 g (0.43 mole) of 6α-brompenicillanic acid sulfoxide and 162 ml of 50% by weight potassium 2-ethylhexanoic acid in n-butanol.
Efter omrøring i 1 time ved 22° opsamledes produktet ved filtrering, vaskedes med 2 x 250 ml acetone og tørredes. Der opnåedes 127 g (90%) kalium-6a-brompenicillanat-sulfoxid, smp. 185°. IR-og NMR-spektrene var 30 konsistente for den ønskede struktur.After stirring for 1 hour at 22 °, the product was collected by filtration, washed with 2 x 250 ml of acetone and dried. 127 g (90%) of potassium 6a-brompenicillanate sulfoxide, m.p. 185 °. The IR and NMR spectra were consistent for the desired structure.
Analyse for CgHgBrKN04S:Analysis for CgHgBrKNO4S:
Beregnet: C: 28,75, H: 2,71, N: 4,19.Calculated: C: 28.75, H: 2.71, N: 4.19.
Fundet: C: 29,03, H: 2,78, N: 4,04.Found: C: 29.03, H: 2.78, N: 4.04.
35 1035 10
DK 164938 BDK 164938 B
Fremstilling af udgangsmaterialet p-nitrobenzvl-6o;-brompenicillanat-sulfoxidPreparation of the starting material p-nitrobenzyl-60; brompenicillanate sulfoxide
O OISLAND ISLAND
ώ + Br Λ 5ώ + Br Λ 5
Jr- --"'sCOzK J— *C02 MW 431-28 10Jr- - '' sCOzK J— * C02 MW 431-28 10
Til 1 liter Ν,Ν-dimethylacetamid sattes 145 g (0,43 mol) kalium-6a-brompenicillanat-sulfoxid, og, under omrøring, tilsattes 115 g (0,53 mol) p-nitrobenzylbromid ved 22°. Blandingen omrørtes ved 22° i 20 timer.To 1 liter of Ν, Ν-dimethylacetamide was added 145 g (0.43 mole) of potassium 6a-brompenicillanate sulfoxide and, with stirring, 115 g (0.53 mole) of p-nitrobenzyl bromide was added at 22 °. The mixture was stirred at 22 ° for 20 hours.
15 Reaktionsblandingen hsldtes i 3 liter HgO og ekstraheredes med 3 x 1500 ml ethyl acetat. De forenede ethyl acetatekstrakter vaskedes med 2 x 500 ml 5% vandig natriumbicarbonatopløsning og tørredes over natriumsulfat i ½ time. Natriumsulfatet frafiltreredes, og filtratet inddampedes under reduceret tryk til en remanens, hvortil der sattes 1 20 liter diethylether, hvilket forårsagede krystallisation af produktet. Krystallerne opsamledes ved filtrering, vaskedes med 2 x 100 ml diethylether og tørredes til et udbytte på 162 g (87¾) p-nitrobenzyl-6a-brom-penicillanat-sulfoxid, smp. 111°. IR- og NMR-spektrene var konsistente for den ønskede struktur.The reaction mixture was poured into 3 liters of HgO and extracted with 3 x 1500 ml of ethyl acetate. The combined ethyl acetate extracts were washed with 2 x 500 ml 5% aqueous sodium bicarbonate solution and dried over sodium sulfate for ½ hour. The sodium sulfate was filtered off and the filtrate was evaporated under reduced pressure to a residue to which was added 1 20 liters of diethyl ether which caused crystallization of the product. The crystals were collected by filtration, washed with 2 x 100 ml diethyl ether and dried to yield 162 g (87¾) of p-nitrobenzyl-6a-bromo-penicillanate sulfoxide, m.p. 111 °. The IR and NMR spectra were consistent for the desired structure.
25 Analyse for CjgHjgBrNgOgS:Analysis for CjgHjgBrNgOgS:
Beregnet: C: 41,78, H: 3,51, N: 6,50.Calculated: C: 41.78, H: 3.51, N: 6.50.
Fundet: C: 41,66, H: 3,45, N: 6,85, HgO: 0,69.Found: C: 41.66, H: 3.45, N: 6.85, HgO: 0.69.
Fremstilling af produktet p-nitrobenzyl-6ft-brom-2g-chlormethyl-2-30 methylpenam-3-carboxyl at σ * A Br _>S iCH2C1 '"i-{ "Ί-. _^ r~f p"CH, 35 J—"' % CEfi\ Nn <t~h _ O C02CH2Aci/ N02 C02C^-\y—K02 MW 449.71Preparation of the product p-nitrobenzyl-6ft-bromo-2g-chloromethyl-2-30 methylpenam-3-carboxyl at σ * A Br _> S iCH 2 Cl 1 "i- {" Ί-. _ ^ r ~ f p "CH, 35 J—"% CEfi \ Nn <t ~ h _ O C02CH2Aci / N02 C02C ^ - \ y — K02 MW 449.71
DK 164938 BDK 164938 B
ππ
Til 1 liter p-dioxan sattes 70 g (0,16 mol) p-nitrobenzyl-6a-brom-penicillanat-sulfoxid efterfulgt af 21,2 ml (0,10 mol) benzoylchlorid og 21,8 ml (0,19 mol) quinolin. Reaktionsblandingen tilbagesvaledes i 4 timer og afkøledes derpå til 22°, hældtes i 2500 ml HgO og ekstraheredes 5 i 3 x 800 ml ethyl acetat. De forenede ethyl acetatekstrakter vaskedes med 300 ml 5% vandig natriumbicarbonatopløsning, 300 ml 5% vandig phosphor-syre og 300 ral HgO. Ethyl acetatopløsningen tørredes over natriumsulfat i ½ time, og natriumsulfatet fjernedes ved filtrering. Filtratet inddampedes under reduceret tryk til en remanens, som genopløstes i 1 liter 10 ethyl acetat og igen inddampedes under reduceret tryk til en remanens.To 1 liter of p-dioxane was added 70 g (0.16 mole) of p-nitrobenzyl-6a-bromo-penicillanate sulfoxide, followed by 21.2 ml (0.10 mole) of benzoyl chloride and 21.8 ml (0.19 mole). quinoline. The reaction mixture was refluxed for 4 hours and then cooled to 22 °, poured into 2500 ml of HgO and extracted 5 in 3 x 800 ml of ethyl acetate. The combined ethyl acetate extracts were washed with 300 ml of 5% aqueous sodium bicarbonate solution, 300 ml of 5% aqueous phosphoric acid and 300 ml of HgO. The ethyl acetate solution was dried over sodium sulfate for ½ hour and the sodium sulfate removed by filtration. The filtrate was evaporated under reduced pressure to a residue which was redissolved in 1 liter of ethyl acetate and again evaporated under reduced pressure to a residue.
Derpå tilsattes 1 liter diethylether, og produktet opsamledes ved filtrering til et udbytte på 41 g (57%) p-nitrobenzyl-6a-brom-2j8-chlor-methyl-2-methylpenam-3-carboxylat, smp. 132°. IR- og NMR-spektrene var konsistente for den ønskede struktur.Then 1 liter of diethyl ether was added and the product was collected by filtration to yield 41 g (57%) of p-nitrobenzyl-6α-bromo-2β-chloro-methyl-2-methylpenam-3-carboxylate, m.p. 132 °. The IR and NMR spectra were consistent for the desired structure.
15 Analyse for CjgHj^BrClNgOgS:Analysis for CjgH₂ ^BrClNOO₂S:
Beregnet: C: 40,06, H: 3,14, N: 6,23.Calculated: C: 40.06, H: 3.14, N: 6.23.
Fundet: C: 40,62, H: 3,11, N: 6,13.Found: C: 40.62, H: 3.11, N: 6.13.
Eksempel 5 20 Fremstilling af kaliumsaltet af 2fl-chlormethyl-2tt-methylpenam-3tt- carboxylsul fon I (den i dansk patentansøgning nr. 218/81 omhandlede BL-P2013) oExample 5 Preparation of the potassium salt of 2fl-chloromethyl-2tt-methylpenam-3tt-carboxyl sulfone I (the BL-P2013 disclosed in Danish Patent Application No. 218/81)
Br , . ^PH,C1 Br__^'S\/'™2C1 25 ppp2 _ pi 3 0J—n ^co2-CH2p)-No2 é N ^2-ch2h@^o2 H2Br,. ^ PH, C1 Br __ ^ 'S \ /' ™ 2C1 25 ppp2 _ pi 3 OJ (n ^ co2-CH2p) -No2
30 i I30 in I
Ψ — O — o -v /0 • f CH-C1 A.CHLC1 n ^ ÅΨ - O - o -v / 0 • f CH-C1 A.CHLC1 n ^ Å
35 rppcH2 ^ ^ pi '^h3 /-N—ΐθ2Η r-" ^C02K35 rppcH2 ^^ pi '^ h3 / -N — ΐθ2Η r- "^ CO2K
sp
DK 164938BDK 164938B
12 p-nitrobenzyl-2fl-chlormethyl-2a-methylpenam-6ct-carboxylat-sulfoxid (4)12 p-Nitrobenzyl-2fl-chloromethyl-2a-methylpenam-6ct carboxylate sulfoxide (4)
En opløsning af 1 g (0,0022 mol) p-nitrobenzyl-30-chlormethyl ^dimethyl-6a-brompenam-3a-carboxyl at (3) opløst i 50 ml methylenchlorid omrørtes med 473 mg (0,0022 mol) m-chlorperoxidbenzoesyre. Opløsningen 5 omrørtes ved 23°C i 3 timer. Methyl enchl ori det inddampes til 20 ml ved 15 mm og 33°C, og den koncentrerede opløsning fortyndedes med 50 ml heptan ("Skellysolve B"). Opløsningsmidlet dekanteredes, og remanensen opslæmmedes med ether, og (4) udkrystalliserede snart i et udbytte på 250 mg, 24%, smp. 136-137°C dek.A solution of 1 g (0.0022 mol) of p-nitrobenzyl-30-chloromethyl-dimethyl-6a-brompenam-3a-carboxyl (3) dissolved in 50 ml of methylene chloride was stirred with 473 mg (0.0022 mol) of m-chloroperoxide benzoic acid. . The solution 5 was stirred at 23 ° C for 3 hours. It was evaporated to 20 ml at 15 mm and 33 ° C, and the concentrated solution was diluted with 50 ml of heptane (Skellysolve B). The solvent was decanted and the residue slurried with ether, and (4) soon crystallized in a yield of 250 mg, 24%, m.p. 136-137 ° C dec.
10 Analyse for CjgHj^BrClNgOgS:Analysis for CjgH₂ ^ BrClNNO₂S:
Beregnet: C: 38,68, H: 3,02, N: 6,02.Calculated: C: 38.68, H: 3.02, N: 6.02.
Fundet: C: 39,14, H: 3,13, N: 5,96.Found: C: 39.14, H: 3.13, N: 5.96.
IR (KBr): 1800(s), 1760(s), 1520(s), 1350(s), 1200(s), 1050(m), 830(w), 740(w) cm"1.IR (KBr): 1800 (s), 1760 (s), 1520 (s), 1350 (s), 1200 (s), 1050 (m), 830 (w), 740 (w) cm
15 H-NMR (60 mHz, DMS0) 8: 1,32 (s, 3H), 3,8-4,5 (m, 2H), 4,97 (s, IH), 5,25 (d, J-1,5 Hz, IH), 5,45 (s, 2H), 5,6 (d, J-1,5 Hz, IH), 7,8- 8,5 (m, 4H).1 H-NMR (60 mHz, DMSO) δ: 1.32 (s, 3H), 3.8-4.5 (m, 2H), 4.97 (s, 1H), 5.25 (d, J -1.5 Hz, 1H), 5.45 (s, 2H), 5.6 (d, J-1.5 Hz, 1H), 7.8- 8.5 (m, 4H).
Kalium-28-chlormethyl-2o;-meth.ylpenam-3tt-carboxylat-sulfon (5) (BL-P2013) 20 Til en opløsning af 7 g (0,015 mol) p-nitrobenzyl-2^-chlormethyl-2a-methyl-6a-brompenam-3tt-carboxylat-sulfoxid (4) i 150 ml ethylacetat sattes en suspension af 4 g 30% palladium-på-diatoméjord ("Celite") og 2,8 g natriumbicarbonat i 150 ml vand. Blandingen hydrogeneredes i 3 timer ved 50 psi. Katalysatoren frasepareredes ved filtrering, og det 25 vandige lag fraskiltes og behandledes med 1,5 g kaliumpermanganat i 50 ml vand. Blandingen omrørtes i 1 time, og 250 ml natriumbisulfit tilsattes. Blandingen filtreredes, og filtratet indstilledes til pH 2 med koncentreret saltsyre. Opløsningen lyof i liseredes til dannelse af et hvidt amorft pulver. Faststoffet ekstraheredes med ethylacetat, inddam-30 pedes til et volumen på 20 ml og fortyndedes med 100 ml heptan ("Skellysolve B"). Hvidt, hygroskopisk, fast 2/?-chlormethyl-2a-methylpenam-3a-carboxylsyre-sulfon opsamledes. Syren opløstes i acetone og behandledes med fast kalium-2-ethylhexanoat. Et krystallinsk hvidt salt udfældede til dannelse, efter filtrering, af 170 mg af 5, smp. >140°C dek.Potassium 28-chloromethyl-2o; -methylpenam-3tt-carboxylate sulfone (5) (BL-P2013) To a solution of 7 g (0.015 mole) of p-nitrobenzyl-2 6a-brompenam-3tt-carboxylate sulfoxide (4) in 150 ml of ethyl acetate was added a suspension of 4 g of 30% palladium-on-diatomaceous earth ("Celite") and 2.8 g of sodium bicarbonate in 150 ml of water. The mixture was hydrogenated for 3 hours at 50 psi. The catalyst was separated by filtration and the aqueous layer was separated and treated with 1.5 g of potassium permanganate in 50 ml of water. The mixture was stirred for 1 hour and 250 ml of sodium bisulfite was added. The mixture was filtered and the filtrate was adjusted to pH 2 with concentrated hydrochloric acid. The solution was lyophilized to form a white amorphous powder. The solid was extracted with ethyl acetate, evaporated to a volume of 20 ml and diluted with 100 ml of heptane (Skellysolve B). White, hygroscopic solid 2β-chloromethyl-2α-methylpenam-3α-carboxylic acid sulfone was collected. The acid was dissolved in acetone and treated with solid potassium 2-ethyl hexanoate. A crystalline white salt precipitated to form, after filtration, 170 mg of 5, m.p. > 140 ° C dec.
35 Analyse for CgHyClKNOgS^HgO:Analysis for CgHyClKNOgS3 HgO:
Beregnet: C: 28,27, H: 3,24, N: 4,12.Calculated: C: 28.27, H: 3.24, N: 4.12.
Fundet: C: 28,27, H: 3,69, N: 3,84.Found: C: 28.27, H: 3.69, N: 3.84.
IR (KBr): 1790(s), 1770(m), 1620(s), 1460(m), 1370(s), 1310(s), 13IR (KBr): 1790 (s), 1770 (m), 1620 (s), 1460 (m), 1370 (s), 1310 (s), 13
DK 164938 BDK 164938 B
1200(s), 1140(s), 955(m), 740(m) cm'1.1200 (s), 1140 (s), 955 (m), 740 (m) cm -1.
H-NMR (100 mHz, D20) δ: 1,68 (s, 3H), 3,2-3,9 (m, H~2 Hz, J~4 Hz, J-6 Hz, 2H), 4,0-4,4 (m, 2H), 4,3 (s, IH), 5,02 (d d, J~4 Hz, J~2 Hz, IH).H NMR (100 mHz, D 2 O) δ: 1.68 (s, 3H), 3.2-3.9 (m, H ~ 2 Hz, J ~ 4 Hz, J-6 Hz, 2H) 0-4.4 (m, 2H), 4.3 (s, 1H), 5.02 (dd, J ~ 4 Hz, J ~ 2 Hz, 1H).
55
Claims (3)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11389480A | 1980-01-21 | 1980-01-21 | |
US11389480 | 1980-01-21 | ||
US21483180A | 1980-12-11 | 1980-12-11 | |
US21483180 | 1980-12-11 | ||
US21483380 | 1980-12-11 | ||
US06/214,833 US4340539A (en) | 1980-01-21 | 1980-12-11 | Derivatives of 6-bromo penicillanic acid |
Publications (4)
Publication Number | Publication Date |
---|---|
DK285890D0 DK285890D0 (en) | 1990-11-30 |
DK285890A DK285890A (en) | 1990-11-30 |
DK164938B true DK164938B (en) | 1992-09-14 |
DK164938C DK164938C (en) | 1993-02-01 |
Family
ID=27381401
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK021881A DK162717C (en) | 1980-01-21 | 1981-01-19 | METHOD FOR PREPARING 2BETA-CHLORMETHYL-2ALFA-METHYLPENAM-3ALFA-CARBOXYL ACID SULPHONES AND SALTS AND ESTERS THEREOF |
DK285790A DK162769C (en) | 1980-01-21 | 1990-11-30 | PROCEDURE FOR PREPARING 2BETA-CHLORMETHYL-2ALFA-METHYLPENAM-3ALFA-CARBOXYLIC ACID SULPHON AND PHARMACEUTICAL ACCEPTABLE SALTS AND ESTERS THEREOF |
DK285890A DK164938C (en) | 1980-01-21 | 1990-11-30 | 2BETA-CHLORMETHYL-2ALFA-METHYL-6ALFA-BROMPENAM-3ALFA-CARBOXYLIC ACID ESTES AND PROCEDURES FOR PREPARING THEREOF |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK021881A DK162717C (en) | 1980-01-21 | 1981-01-19 | METHOD FOR PREPARING 2BETA-CHLORMETHYL-2ALFA-METHYLPENAM-3ALFA-CARBOXYL ACID SULPHONES AND SALTS AND ESTERS THEREOF |
DK285790A DK162769C (en) | 1980-01-21 | 1990-11-30 | PROCEDURE FOR PREPARING 2BETA-CHLORMETHYL-2ALFA-METHYLPENAM-3ALFA-CARBOXYLIC ACID SULPHON AND PHARMACEUTICAL ACCEPTABLE SALTS AND ESTERS THEREOF |
Country Status (12)
Country | Link |
---|---|
KR (1) | KR850001066B1 (en) |
CA (1) | CA1175807A (en) |
CH (2) | CH651571A5 (en) |
DE (1) | DE3101527A1 (en) |
DK (3) | DK162717C (en) |
GB (1) | GB2070592B (en) |
HU (2) | HU184380B (en) |
IL (1) | IL61880A (en) |
NL (1) | NL8100209A (en) |
NO (5) | NO160298C (en) |
OA (1) | OA06748A (en) |
SE (5) | SE455702B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA826687B (en) * | 1981-09-14 | 1983-07-27 | Pfizer | Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl 5(r)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor |
ATE27772T1 (en) * | 1983-09-15 | 1987-07-15 | Bristol Myers Co | PHARMACEUTICAL COMPOSITIONS TO COMBAT THE RESISTANCE OF BACTERIAL ANAEROBIA. |
GB2157286B (en) * | 1984-04-12 | 1987-12-31 | Leo Pharm Prod Ltd | B-lactam antibiotic potentiators |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN149747B (en) * | 1977-06-07 | 1982-04-03 | Pfizer | |
DE2912511C2 (en) * | 1977-06-07 | 1982-06-24 | Pfizer Inc., 10017 New York, N.Y. | Pharmaceutical composition containing penicillanic acid |
IE49880B1 (en) * | 1979-02-13 | 1986-01-08 | Leo Pharm Prod Ltd | Penicillin derivatives |
GB2045236A (en) * | 1979-03-26 | 1980-10-29 | Hoechst Uk Ltd | Oxapenem derivatives |
US4244951A (en) * | 1979-05-16 | 1981-01-13 | Pfizer Inc. | Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide |
-
1981
- 1981-01-08 IL IL61880A patent/IL61880A/en unknown
- 1981-01-15 CA CA000368537A patent/CA1175807A/en not_active Expired
- 1981-01-16 NL NL8100209A patent/NL8100209A/en not_active Application Discontinuation
- 1981-01-16 GB GB8101365A patent/GB2070592B/en not_active Expired
- 1981-01-19 DE DE19813101527 patent/DE3101527A1/en not_active Withdrawn
- 1981-01-19 DK DK021881A patent/DK162717C/en not_active IP Right Cessation
- 1981-01-20 HU HU81115A patent/HU184380B/en not_active IP Right Cessation
- 1981-01-20 HU HU833171A patent/HU188606B/en not_active IP Right Cessation
- 1981-01-20 NO NO810166A patent/NO160298C/en unknown
- 1981-01-21 SE SE8100339A patent/SE455702B/en not_active IP Right Cessation
- 1981-01-21 CH CH374/81A patent/CH651571A5/en not_active IP Right Cessation
- 1981-01-21 CH CH1284/84A patent/CH649087A5/en not_active IP Right Cessation
- 1981-02-19 OA OA57331A patent/OA06748A/en unknown
-
1984
- 1984-07-21 KR KR1019840004326A patent/KR850001066B1/en not_active IP Right Cessation
-
1985
- 1985-05-08 SE SE8502285A patent/SE8502285L/en not_active Application Discontinuation
- 1985-05-08 SE SE8502286A patent/SE466203B/en not_active IP Right Cessation
- 1985-09-03 NO NO85853450A patent/NO161677C/en unknown
-
1986
- 1986-05-16 NO NO86861944A patent/NO164298C/en unknown
- 1986-05-16 NO NO86861945A patent/NO164299C/en unknown
- 1986-05-16 NO NO86861946A patent/NO164300C/en unknown
-
1990
- 1990-01-19 SE SE9000190A patent/SE9000190L/en not_active Application Discontinuation
- 1990-01-19 SE SE9000189A patent/SE9000189L/en not_active Application Discontinuation
- 1990-11-30 DK DK285790A patent/DK162769C/en not_active IP Right Cessation
- 1990-11-30 DK DK285890A patent/DK164938C/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI453202B (en) | Process and intermediates for preparing lapatinib | |
CN111620849B (en) | Process for preparing diaryl thiohydantoin compounds | |
JP3174405B2 (en) | 8-vinyl- and 8-ethynyl-quinolone-carboxylic acids | |
EP1383770A1 (en) | Method for the production of 4,6-diaminopyrimido 5,4-d]pyrimidines | |
JPS59122470A (en) | Preparation of quinoline-3-carboxylic acid derivative | |
DK164938B (en) | 2BETA-CHLORMETHYL-2ALFA-METHYL-6ALFA-BROMPENAM-3ALFA-CARBOXYLIC ACID ESTES AND PROCEDURES FOR PREPARING THEREOF | |
JP2023526351A (en) | Method for producing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine carboxylate | |
RU2303029C2 (en) | Novel method for preparing 4-aminomethyl-3-alkoxyiminopyrrolidine methanesulfonate (variants), intermediate compounds and method for preparing quinolone antibiotics | |
JP4480172B2 (en) | Method for producing uracil derivative | |
CN114560862A (en) | Synthesis method of pyrrolo [1,2-A ] quinoxaline-4 (5H) -ketone and derivative thereof | |
AU2008333153A1 (en) | Process for the preparation of 2-(primary/secondary amino)hydrocarbyl)- carbamoyl-7-oxo-2,6-diaza-bicyclo[3.2.0.]heptane-6-sulfonic acid derivatives | |
WO2021120953A1 (en) | Method for synthesizing 1,7-naphthyridine derivative | |
EP4013416A1 (en) | Process for preparing 1,4-dihydro-4-oxoquinoline-2-carboxylates and 4-aminoquinoline compounds therefrom | |
JPH0641135A (en) | Imidazopteridine derivative and its production | |
WO2015188762A1 (en) | Method for preparing anti-angiogenic compound and intermediate thereof | |
JP4425366B2 (en) | Process for producing N-benzyl-3-hydroxyazetidine | |
JP7279134B2 (en) | Method for producing prolinamide compound | |
CN116283797B (en) | A kind of synthetic method of elagolid sodium | |
JP7536950B2 (en) | Method for producing prolinamide compound | |
JPH05255212A (en) | Preparation of halogenoanthranilic acid | |
JP2893182B1 (en) | 2,7-diaza-1,2,3,6,7,8-hexahydropyrene compound and method for producing the same | |
WO2023006986A1 (en) | Method for preparing and purifying an agent suitable for treating anemia | |
JPH0940652A (en) | Production of uracil derivative | |
JPH07267950A (en) | Production of 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazole-4-amine or its acid-added salt | |
RU2282632C1 (en) | Method for preparing derivatives of 3,5-dihydro-1,11-dimethylfuro[2',3':3,4]cyclohepta[c]isoquinoline-5-one |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |